No. 21-406 | |
Title: | Impax Laboratories, Inc., Petitioner v. Federal Trade Commission |
Docketed: | September 15, 2021 |
Lower Ct: | United States Court of Appeals for the Fifth Circuit |
Case Numbers: | (19-60394) |
Decision Date: | April 13, 2021 |
Date | Proceedings and Orders |
Sep 10 2021 | Petition for a writ of certiorari filed. (Response due October 15, 2021) |
PetitionAppendixCertificate of Word CountProof of Service | |
Oct 05 2021 | Motion to extend the time to file a response from October 15, 2021 to November 15, 2021, submitted to The Clerk. |
Main Document | |
Oct 06 2021 | Motion to extend the time to file a response is granted and the time is extended to and including November 15, 2021. |
Oct 15 2021 | Brief amicus curiae of Association for Accessible Medicines filed. |
Main DocumentCertificate of Word CountProof of ServiceOther | |
Nov 15 2021 | Brief of respondent Federal Trade Commission in opposition filed. |
Main DocumentProof of Service | |
Nov 22 2021 | Waiver of the 14-day waiting period under 15.5 filed. |
Main Document | |
Nov 23 2021 | DISTRIBUTED for Conference of 12/10/2021. |
Nov 23 2021 | Reply of Impax Laboratories, Inc. not accepted for filing. (November 23, 2021) |
Nov 23 2021 | Reply of petitioner Impax Laboratories, Inc. filed. (Distributed) |
Main DocumentCertificate of Word CountProof of Service | |
Dec 13 2021 | Petition DENIED. |
NAME | ADDRESS | PHONE |
Attorneys for Petitioner | ||
Jay Philip Lefkowitz Counsel of Record | Kirkland & Ellis LLP 601 Lexington Ave. New York, NY 10022 lefkowitz@kirkland.com | (212) 446-4800 |
Party name: Impax Laboratories, Inc. | ||
Attorneys for Respondent | ||
Elizabeth B. Prelogar Counsel of Record | Solicitor General United States Department of Justice 950 Pennsylvania Avenue, NW Washington, DC 20530-0001 SupremeCtBriefs@USDOJ.gov | 202-514-2217 |
Party name: United States | ||
Other | ||
Brian Timothy Burgess Counsel of Record | Goodwin Procter, LLP 1900 N Street, N.W. Washington, DC 20036 BBurgess@goodwinlaw.com | 2023464000 |
Party name: Association for Accessible Medicines |